logo

For the Inventor, By the Inventor

Acton, MA, United States of America

Jason B O'Connor

This inventor holds 40 USPTO granted patents and 57 published patent applications and 7 EPO patents, primarily in Automated Insulin Delivery. Top assignees: Insulet Corporation, Nova Biomedical Corporation. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jason B O'Connor. Retrieved from https://idiyas.com/inventor/jason-b-o-connor

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 40 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.4

ph-index = 8

Forward Citations = 359(Granted Patents)


Location History:

  • South Boston, MA (US) (2011 - 2022)
  • Acton, MA (US) (2019 - 2024)

Company Filing History:

goldMedal40 out of 242 
 
Insulet Corporation
 patents
silverMedal1 out of 64 
 
Nova Biomedical Corporation
 patents
where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Insulin Delivery
Glucose Monitor
Drug Delivery Device
Personalized Treatment
Closed Loop System
Hypoglycemia Risk
Wearable Technology
Adaptive Algorithms
Blood Glucose Monitoring
Medication Delivery
Event Detection
Fluid Regulation
40 patents (USPTO):Explore Patents
1. 12257420 - Initial total daily insulin setting for user onboarding (2025-03-25),
2. 12226612 - Compensation for missing readings from a glucose monitor in an automated insulin delivery system (2025-02-18),
3. 12121701 - Systems and methods for incorporating co-formulations of insulin in an automatic insulin delivery system (2024-10-22),
4. 12121700 - Open-loop insulin delivery basal parameters based on insulin delivery records (2024-10-22),
5. 12097352 - Wearable micro-dosing drug delivery device (2024-09-24),
6. 12090301 - Safety constraints for a control algorithm based drug delivery system (2024-09-17),
7. 12036389 - Prediction of meal and/or exercise events based on persistent residuals (2024-07-16),
8. 11992653 - Drug delivery insertion apparatuses and system (2024-05-28),
9. 11986630 - Dual hormone delivery system for reducing impending hypoglycemia and/or hyperglycemia risk (2024-05-21),
10. 11957875 - Techniques and devices providing adaptivity and personalization in diabetes treatment (2024-04-16),
11. 11935637 - Onboarding and total daily insulin adaptivity (2024-03-19),
12. 11911596 - Initial total daily insulin setting for user onboarding (2024-02-27),
13. 11904140 - Adaptable asymmetric medicament cost component in a control system for medicament delivery (2024-02-20),
14. 11883632 - Safety constraints for a control algorithm based drug delivery system (2024-01-30),
15. 11833329 - Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns (2023-12-05),

Title: The Innovative Mind of Jason B O'Connor

Introduction

Jason B O'Connor, an accomplished inventor based in Acton, MA, holds an impressive portfolio of 41 patents. His innovative contributions in the field of automated insulin delivery systems demonstrate his commitment to advancing medical technology and improving the lives of people with diabetes.

Latest Patents

Among his latest patents, Jason developed a method for providing compensation for missing readings from a glucose monitor in an automated insulin delivery system. This invention addresses the challenge posed by missing blood glucose concentration readings, facilitating uninterrupted operation of insulin delivery even when wireless transmission fails. By using estimates to substitute missing readings, automated insulin delivery devices are able to continue functioning without needing to suspend insulin delivery.

Another significant patent involves systems and methods for incorporating co-formulations of insulin within an automated insulin delivery system. The invention provides a framework for calculating insulin doses while accounting for the effect of a second drug, such as GLP-1. This innovation enables a more tailored approach to insulin delivery, enhancing the overall effectiveness of diabetes management for users.

Career Highlights

Jason has made substantial contributions to the biomedical field during his career at notable companies, including Insulet Corporation and Nova Biomedical Corporation. His work at these organizations has been instrumental in advancing automated healthcare solutions.

Collaborations

Throughout his career, Jason has collaborated with talented individuals including Joon Bok Lee and Yibin Zheng. These partnerships have fostered a dynamic exchange of ideas, resulting in impactful inventions that push the boundaries of current technology in diabetes care.

Conclusion

Jason B O'Connor's innovative spirit and dedication to enhancing automated insulin delivery systems mark him as a significant figure in medical technology. His numerous patents reflect a strong commitment to improving patient outcomes, establishing him as a leading inventor in the field. Through his groundbreaking work, Jason continues to contribute to the ongoing quest for better healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…